Losing weight was never easy for me, but in my 30s, it became increasingly more difficult. No matter how I exercised and dieted, the loss was minimal and impermanent. Yet every time I went to a doctor ...
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.